Cigarette smokers differ in their handling of natural (RRR) and synthetic (all rac) alpha-tocopherol: a biokinetic study in apoE4 male subjects.

[1]  C. Lii,et al.  Alterations of small-molecular-weight antioxidants in the blood of smokers. , 1998, Chemico-biological interactions.

[2]  C. Cross,et al.  Studies in humans using deuterium-labeled α- and γ-tocopherols demonstrate faster plasma γ-tocopherol disappearance and greater γ-metabolite production , 2005 .

[3]  R J Edwards,et al.  Expression of CYP1A1, CYP1B1 and CYP3A, and polycyclic aromatic hydrocarbon‐DNA adduct formation in bronchoalveolar macrophages of smokers and non‐smokers , 2000, International journal of cancer.

[4]  R. Brigelius-Flohé,et al.  A rapid method for the extraction and determination of vitamin E metabolites in human urine. , 2000, Journal of lipid research.

[5]  R. Brigelius-Flohé,et al.  Vitamin E kinetics in smokers and nonsmokers. , 2001, Free radical biology & medicine.

[6]  B. Adams-Huet,et al.  Dose-Response Comparison of RRR-α-Tocopherol and All-Racemic α-Tocopherol on LDL Oxidation , 1997 .

[7]  K. Ingold,et al.  A mild, rapid, and efficient method of lipid extraction for use in determining vitamin E/lipid ratios , 2006, Lipids.

[8]  K. Prasad,et al.  Increased production of oxygen free radicals in cigarette smokers. , 1991, International journal of experimental pathology.

[9]  M. Hori,et al.  Protective effect of apolipoprotein E against ischemic neuronal injury is mediated through antioxidant action , 2002, Journal of neuroscience research.

[10]  M. Faruque,et al.  Relationship between smoking and antioxidant nutrient status , 1995, British Journal of Nutrition.

[11]  W. James,et al.  Effects of smoking and vitamin E on blood antioxidant status. , 1991, The American journal of clinical nutrition.

[12]  M. Traber,et al.  Human plasma and tissue alpha-tocopherol concentrations in response to supplementation with deuterated natural and synthetic vitamin E. , 1998, The American journal of clinical nutrition.

[13]  G. Davı̀,et al.  Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease. , 1997, Circulation.

[14]  K. Rahman,et al.  Dietary supplementation with aged garlic extract reduces plasma and urine concentrations of 8-iso-prostaglandin F(2 alpha) in smoking and nonsmoking men and women. , 2002, The Journal of nutrition.

[15]  R. Anderson,et al.  Pro-Oxidant Effect of Vitamin E in Cigarette Smokers Consuming a High Polyunsaturated Fat Diet , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[16]  P. Pfluger,et al.  Modulation of Cyp3a11 mRNA expression by α-tocopherol but not γ-tocotrienol in mice , 2005 .

[17]  L. Neveux,et al.  The relationship between apolipoprotein E and serum oxidation-related variables is apolipoprotein E phenotype dependent , 1998, International journal of clinical & laboratory research.

[18]  F. Kelly,et al.  Plasma RRR-alpha-tocopherol concentrations are lower in smokers than in non-smokers after ingestion of a similar oral load of this antioxidant vitamin. , 1997, Clinical science.

[19]  F. Cuccurullo,et al.  Vitamins E, C and lipid peroxidation in plasma and arterial tissue of smokers and non-smokers. , 1995, Atherosclerosis.

[20]  Y. Christen,et al.  Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype. , 1999, Free radical biology & medicine.

[21]  T. Montine,et al.  {alpha}-Tocopherol disappearance is faster in cigarette smokers and is inversely related to their ascorbic acid status. , 2005, The American journal of clinical nutrition.

[22]  G. Duthie,et al.  Vitamin E supplementation suppresses indexes of lipid peroxidation and platelet counts in blood of smokers and nonsmokers but plasma lipoprotein concentrations remain unchanged. , 1994, The American journal of clinical nutrition.

[23]  E. Hawe,et al.  Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study , 2001, The Lancet.

[24]  W. Hall,et al.  Development of a liquid chromatographic time-of-flight mass spectrometric method for the determination of unlabelled and deuterium-labelled alpha-tocopherol in blood components. , 2003, Rapid communications in mass spectrometry : RCM.

[25]  William A. Pryor,et al.  The Tar Radical ( s ) in Cigarette Smoke : ESR Studies , 2006 .

[26]  R. Mahley,et al.  Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond. , 1999, Current opinion in lipidology.

[27]  J. Morrow,et al.  Antioxidant supplementation decreases lipid peroxidation biomarker F(2)-isoprostanes in plasma of smokers. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[28]  H. Poulsen,et al.  Ascorbic acid recycling in human erythrocytes is induced by smoking in vivo. , 2003, Free radical biology & medicine.

[29]  Jonathan D. Smith,et al.  Apolipoprotein E allele–specific antioxidant activity and effects on cytotoxicity by oxidative insults and β–amyloid peptides , 1996, Nature Genetics.

[30]  A. Minihane,et al.  Noncompetitive plasma biokinetics of deuterium-labeled natural and synthetic alpha-tocopherol in healthy men with an apoE4 genotype. , 2005, The Journal of nutrition.

[31]  J. Morrow,et al.  Vitamin C Supplementation Decreases Oxidative Stress Biomarker F2-Isoprostanes in Plasma of Nonsmokers Exposed to Environmental Tobacco Smoke , 2003, Nutrition and cancer.

[32]  R. Brigelius-Flohé,et al.  Tocopherols are metabolized in HepG2 cells by side chain ω-oxidation and consecutive β-oxidation , 2001 .

[33]  H. Glatt,et al.  Vitamin E activates gene expression via the pregnane X receptor. , 2003, Biochemical pharmacology.

[34]  J. Morrow,et al.  Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. , 1995, The New England journal of medicine.

[35]  Meir J Stampfer,et al.  Meta-Analysis: Apolipoprotein E Genotypes and Risk for Coronary Heart Disease , 2004, Annals of Internal Medicine.

[36]  A. Oke,et al.  Simultaneous high-performance liquid chromatographic determination of ascorbic acid and dehydroascorbic acid in biological samples. , 1991, Journal of chromatography.

[37]  R. Bruno,et al.  Lower plasma α-carboxyethyl-hydroxychroman after deuterium-labeled α-tocopherol supplementation suggests decreased vitamin E metabolism in smokers , 2005 .

[38]  A. Papas,et al.  Relative bioavailability of RRR- and all-rac-alpha-tocopheryl acetate in humans: studies using deuterated compounds. , 1994, The American journal of clinical nutrition.

[39]  D. T. Vernier,et al.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.

[40]  M. Reilly,et al.  Modulation of oxidant stress in vivo in chronic cigarette smokers. , 1996, Circulation.

[41]  M. Schuelke,et al.  Urinary α-tocopherol metabolites in α-tocopherol transfer protein-deficient patients , 2000 .

[42]  C. Cross,et al.  5-nitro-γ-tocopherol increases in human plasma exposed to cigarette smoke in vitro and in vivo , 2003 .

[43]  Alan D. Lopez,et al.  Mortality from tobacco in developed countries: indirect estimation from national vital statistics , 1992, The Lancet.

[44]  Y. Christen,et al.  Impact of apoE deficiency on oxidative insults and antioxidant levels in the brain. , 2001, Brain research. Molecular brain research.

[45]  M. Traber,et al.  Human plasma vitamin E kinetics demonstrate rapid recycling of plasma RRR-alpha-tocopherol. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[46]  W. Hall,et al.  Cigarette Smokers have Decreased Lymphocyte and Platelet α-tocopherol Levels and Increased Excretion of the γ-tocopherol Metabolite γ-carboxyethyl-hydroxychroman (γ-CEHC) , 2004, Free radical research.

[47]  S. Peroutka,et al.  The value of genotyping for apolipoprotein E alleles in relation to vitamin E supplementation. , 2000, European journal of pharmacology.

[48]  P. Talmud,et al.  ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[49]  B. Ames,et al.  Ascorbate is depleted by smoking and repleted by moderate supplementation: a study in male smokers and nonsmokers with matched dietary antioxidant intakes. , 2000, The American journal of clinical nutrition.

[50]  Frank J. Kelly,et al.  Free radicals : a practical approach , 1996 .

[51]  S. Anttila,et al.  Regulation of CYP3A5 by Glucocorticoids and Cigarette Smoke in Human Lung-Derived Cells , 2003, Journal of Pharmacology and Experimental Therapeutics.

[52]  G. Davı̀,et al.  Effects of vitamin E supplementation on F(2)-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. , 2000, Circulation.

[53]  A. Lichtenstein,et al.  Effects of ApoE genotype on ApoB-48 and ApoB-100 kinetics with stable isotopes in humans. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[54]  G. Block,et al.  Smoking and exposure to environmental tobacco smoke decrease some plasma antioxidants and increase gamma-tocopherol in vivo after adjustment for dietary antioxidant intakes. , 2003, The American journal of clinical nutrition.